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INTRODUCTION 
The United States Department of Energy (U.S. DOE) has recently implemented a series 
of strategic initiatives to address long-term radiological surveillance needs at former U.S. 
nuclear test sites in the Marshall Islands. The plan is to engage local atoll communities in 
developing shared responsibilities for implementing radiation protection monitoring 
programs for resettled and resettling populations in the northern Marshall Islands. Using 
the pooled resources of the U.S. DOE and local atoll governments, individual radiological 
surveillance programs have been developed in whole body counting and plutonium 
urinalysis in order to accurately assess radiation doses resulting from the ingestion and 
uptake of fallout radionuclides contained in locally grown foods. 
Permanent whole body counting facilities have been established at three separate 
locations in the Marshall Islands (Figure 1). These facilities are operated and maintained 
by Marshallese technicians with scientists from the Lawrence Livermore National 
Laboratory (LLNL) providing on-going technical support services. Bioassay samples are 
collected under controlled conditions and analyzed for plutonium isotopes at the Center 
for Accelerator Mass Spectrometry at LLNL using state-of-the art measurement 
technologies. We also conduct an on-going environmental monitoring and 
characterization program at selected sites in the northern Marshall Islands. The aim of 
the environmental program is to determine the level and distribution of important fallout 
radionuclides in soil, water and local foods with a view towards providing more accurate 
and updated dose assessments, incorporating knowledge of the unique behaviors and 
exposure pathways of fallout radionuclides in coral atoll ecosystems. These scientific 
studies have also been essential in helping guide the development of remedial options 
used in support of island resettlement. 
Together, the individual and environmental radiological surveillance programs are helping 
meet the informational needs of the U.S. DOE and the Republic of the Marshall Islands. 
Our updated environmental assessments provide a strong scientific basis for predicting 
future change in exposure conditions especially in relation to changes in life-style, diet 
and/or land-use patterns. This information has important implications in addressing 
questions about existing (and future) radiological conditions on the islands, in determining 
the cost and the effectiveness of potential remedial measures, and in general policy 
support considerations. Perhaps most importantly, the recently established individual 
radiological surveillance programs provide affected atoll communities with an 
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unprecedented level of radiation protection monitoring where, for the first time, local 
resources are being made available to monitor resettled and resettling populations on a 
continuous basis. 
As a hard copy supplement to Marshall Islands Program website (http://eed.llnl.gov/mi/), 
this document provides an overview of the individual radiation surveillance monitoring 
program established for the Utrōk Atoll population group along with a full disclosure of all 
verified measurement data (2003-2004). The Utrōk whole body counting facility has been 
temporarily stationed on Majuro Atoll and, in cooperation with the Utrōk Atoll Local 
Government, serves as a national facility open to the general public. Readers are advised 
that an additional feature of the associated website is a provision whereby users are able 
to calculate and track radiation doses delivered to volunteers (de-identified information 
only) participating in the Marshall Islands Radiological Surveillance Program. 
 
Figure 1. President Note of the Republic of the Marshall Islands 
seated in the whole body counting chair on Majuro (Dedication 
Ceremony for the opening of the Utrōk Atoll Whole Body Counting 
Facility, January 2004). 
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BRIEF HISTORY OF NUCLEAR TESTING IN THE MARSHALL ISLANDS 
Immediately after WWII, the United States created a Joint Task Force to develop a 
nuclear weapons testing program. Planners examined a number of possible locations in 
the Atlantic Ocean, the Caribbean, and the Central Pacific but decided that coral atolls in 
the northern Marshall Islands offered the best advantages of stable weather conditions, 
fewest inhabitants to relocate and isolation with hundreds of miles of open-ocean to the 
west where trade winds were likely to disperse radioactive fallout. During the period 
between 1945 and 1958, a total of 67 nuclear tests were conducted on Bikini and 
Enewetak Atolls and adjacent regions within the Republic of the Marshall Islands. The 
most significant contaminating event was the Castle Bravo test conducted on March 1, 
1954 (Figure 2). Bravo was an experimental thermonuclear device with an estimated 
explosive yield of 15 MT (USDOE, 2000), and led to widespread fallout contamination 
over inhabited islands of Rongelap and Utrōk Atolls, as well as other atolls to the east of 
Bikini. Today, the United States Department of Energy (U.S. DOE) through the Office of 
Health Studies continues to provide environmental monitoring, healthcare and medical 
services on the affected atolls. 
 
Figure 2. Map of the Republic of Marshall Islands showing the fallout pattern 
from the Bravo nuclear test conducted on March 1 of 1954. 
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Key directives of the Marshall Islands Dose Assessment and Radioecology Program 
conducted at the Lawrence Livermore National Laboratory are (1) to provide technical 
support services and oversight in establishing radiological surveillance monitoring 
programs for resettled and resettling populations in the northern Marshall Islands; (2) to 
develop comprehensive assessments of current (and potential changing) radiological 
conditions on the islands; and (3) provide recommendations for remediation of 
contaminated sites and verify the effects of any actions taken. 
UTRŌK ATOLL 
People & Events | Historical Data| 
 
People and Events on Utrōk Atoll 
Utrōk Atoll is located about 500 kilometers east of Bikini Atoll. The atoll experienced 
significant radioactive fallout deposition from atmospheric nuclear weapons tests 
conducted in the Northern Marshall Islands during the 1950s. The most significant 
contaminating event on Utrōk Atoll was the Bravo test conducted at Bikini Atoll on March 
1, 1954. The 167 residents (including 8 in utero) living on Utrōk Atoll at the time of the 
blast received significant external and internal exposures to fresh fallout contamination 
before being evacuated to Kwajalein Atoll on March 3, 1954. The Utrōk community 
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returned to their home atoll 3 months later but continues to seek assurances from the 
United States Government that the atoll is safe for habitation. 
The U.S. Department of Energy originally assigned responsibility for the internal 
dosimetry program on Utrōk Atoll to the Brookhaven National Laboratory. Through the 
1990s scientists from Brookhaven conducted periodic whole body counting missions to 
the Marshall Islands to determine the body burdens of gamma-emitting radionuclides 
such as cesium-137, cobolt-60 and potassium-40 in Marshallese from Bikini, Enewetak, 
Rongelap and Utrōk Atolls (Sun et al., 1997). More recently, the U.S. Department of 
Energy has developed a series of initiatives to address long-term radiological surveillance 
needs in the Marshall Islands. Under a working agreement between the Utrōk Atoll Local 
Government, the Republic of the Marshall Islands and the U.S. Department of Energy 
(MOU, 2002), a permanent whole body counting system was established on Majuro 
Island (Majuro Atoll)# during May 2003. With the cooperation of the Utrōk Atoll Local 
Government this facility also serves the general public, especially those residents and 
visitors who return from the northern Marshall Islands and have concerns about being 
exposed to elevated levels of fallout contamination in the environment. Under supervision 
from scientists from the Lawrence Livermore National Laboratory, the Utrōk Whole Body 
Counting Facility on Majuro is maintained and operated by Marshallese technicians. It is 
expected that Utrōk Atoll residents will be able to receive whole body counts during 
scheduled visits to Majuro Atoll under the routine medical surveillance program or on 
occasional outings to the capital. 
Historical Data 
Today, exposure to residual fallout contamination on Utrōk Atoll represents only a small 
fraction of the dose that people receive from natural sources of background radiation in 
the Marshall Islands. The radiological dose delivered to inhabitants living on Utrōk Atoll 
from residual fallout contamination in the environment is dominated by the external 
exposure and ingestion of cesium-137 (and to a lesser extent, strontium-90) contained in 
locally grown food crop products such as coconut, breadfruit and Pandanus. According to 
(Robison et al., 1999), the estimated population average maximum annual effective dose 
on Utrōk Atoll, based on a mixed diet containing imported foods, is less than 0.04 mSv (4 
mrem) per year and has no consequence on the health of the population. Moreover, the 
predictive dose assessments based on environmental data and dietary models 
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developed by the Lawrence Livermore National Laboratory appear to be in excellent 
agreement with estimates based on whole body counting (Robison and Sun, 1997). 
Justification for establishing a permanent whole body counting system on Majuro Atoll for 
use by the Utrōk community comes from renewed concerns about high end doses to 
maximal exposed individuals on Utrōk Atoll and that the associated health risk may 
exceed current guidelines adopted by the Marshall Islands Nuclear Claims Tribunal for 
cleanup of radioactively contaminated sites. Such high-end individual doses in the Utrōk 
population have not been clearly demonstrated but the potential does exist for members 
of the population to binge on a local foods only diet or eat more foods containing higher 
than average radionuclide concentrations, e.g., coconut crab. In addition, a permanent 
whole body counting program will be able to answer other questions including concerns 
about seasonality effects on cesium-137 uptake and dose. Justification for intervention 
could then be made on the presumption that high-end doses are reasonably achievable 
and that the risks from radiation exposures can be reduced by means of remedial actions 
taking into account the relative benefits including social and economic factors. 
 
Figure 3. Whole Body Counting technicians in charge of the Utrōk 
Whole Body Counting Facility (Majuro Atoll, Republic of the 
Marshal Islands). Mr. Sherwood Tibon (standing) and Ms. Lolieta 
Chee (seated). 
# Majuro is the capital city of the Republic of the Marshall Islands and the main hub for the local airline 
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WHOLE BODY COUNTING 
What is Whole Body Counting? | What Will the Whole Body Counting Show? | 
Estimating Doses from Cesium-137 Based on Whole Body Counting | Doses 
Delivered to the Utrōk Population Group as well as other Marshall Islanders from 
Internally Deposited Cesium-137 
What is Whole Body Counting? 
The whole body counting systems installed in the Marshall Islands contain large volume 
sodium iodide radiation detectors that measure gamma rays coming from radionuclides 
deposited in the body. The detector systems are modeled after the ‘Masse-Bolton Chair’ 
design (Figure 4) and can be used to detect high-energy gamma-emitting radionuclides 
from the decay of cesium-137, cobalt-60 and potassium-40 in most of the body and all of 
the internal organs. Using established protocols the whole body counting measurement 
data are converted into an annual effective dose using specially designed computer 
software (Canberra, 1998a; 1998b). 
There are currently three operational whole body counting facilities in the Republic of the 
Marshall Islands. These facilities are located on Enewetak, Rongelap and Majuro Atolls. 
The whole body counting systems are calibrated using a mixed-gamma point source. The 
point source calibration procedure was developed by cross-reference to a Bottle Man-
akin Absorption (BOMAB) phantom (or human surrogate) calibration source containing a 
standard mix of gamma-emitting radionuclides traceable to the U.S. National Institute of 
Standards and Technology (NIST). 
Wherever possible, the whole body counting program in the Marshall Islands is 
conducted using the same quality requirements as established under the U.S. 
Department of Energy Laboratory Accreditation Program (DOELAP) for internal 
dosimetry. Background and other quality control check counts are performed on a daily 
basis to ensure that the measurement system conforms to all applicable quality 
requirements. Also, each whole body counting facility participates in external 
performance testing exercises with the Hazards Control Department at the Lawrence 
Livermore National Laboratory using ‘5 bottle phantoms’ prepared under contract by the 
Oak Ridge National Laboratory. These performance test samples are distributed around 
each of the facilities including a mirror whole body counting system located at Livermore. 
The performance of the facilities is then evaluated by comparing results with those 
obtained by the Hazards Control Department at the Lawrence Livermore National 
Laboratory−a DOELAP accredited facility−and with the reference values supplied by the 
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Oak Ridge National Laboratory. Under this quality assurance program, the data returned 
by these remote facilities in the Marshall Islands has consistently exceeded the ANSI 
13.30 criteria for accuracy and measurement precision.  
Local Marshallese technicians are responsible for all daily operations within the facilities 
including scheduling of personal counts, performing systems performance checks, data 
reduction, and reporting to program volunteers. The technicians receive an initial six 
weeks of intensive training at the Lawrence Livermore National Laboratory and are 
employed to run the facilities for up to 40 hours per week. Scientists from the Lawrence 
Livermore National Laboratory provide on-going technical support services, advanced 
training in whole body counting and basic health physics, and perform a more detailed 
data quality assurance appraisal before the data are released in reports or posted to the 
world-wide web. 
What Will the Whole Body Counting Show? 
The main pathway for exposure to residual fallout contamination in the northern Marshall 
Islands is through ingestion of cesium-137 contained in locally grown foods such as 
coconut, Pandanus fruit and breadfruit. The strategic objective of the Marshall Islands 
Whole Body Counting Program in the Marshall Islands is to offer island residents an 
unprecedented level of radiation protection monitoring until such time that it is clearly 
demonstrated that radiation surveillance measures can be relaxed. The value of this type 
of radiation protection monitoring program lies in the fact that whole body count data 
provides a direct measure of the full range of radionuclide uptakes into the local 
population. Information about potential high-end health risks and seasonal fluctuations in 
the body burden of cesium-137 within exposed Marshallese can be assessed from 
measurement data rather than relying on a range of assumptions from different dietary 
scenarios. 
In combination with environmental monitoring data, residents who receive a whole body 
count showing the presence of cesium-137 can now make an informed decision about 
their eating habits or life-style based on what is considered a “safe” or acceptable health 
risk. The Republic of the Marshall Islands Nuclear Claims Tribunal has adopted a 
standard for cleanup of radioactively contaminated sites of 0.15 millisievert (mSv) per 
year (or 15 mrem per year) [EDE, Effective Dose Equivalent] using a lifetime cancer risk 
criterion recommended by the U.S. Environmental Protection Agency (EPA).  
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Figure 4. A whole body counter with a volunteer seated in the chair. 
As displaced communities return to their ancestral homelands, the Marshall Islands 
Whole Body Counting Program will allow the U.S. Department of Energy to monitor the 
return of the people and help ensure that the radiation related health risks remain at or 
below these established standards. 
Estimating Doses from Cesium-137 based Whole Body Counting 
People living in the Marshall Islands may be exposed to cesium-137 contained in their 
diets from eating locally grown food crop products such as coconut. Whole body counting 
provides a direct measure of the amount of cesium-137 inside the body of people. The 
biokinectic behavior of cesium-137 inside the human body is well known and allows 
information from the whole body counter to be converted to a radiation dose. The 
radiation dose is what is used to quantify the potential human health risk associated with 
radiation exposure. The dosimetric data displayed in graphics presented in this report 
and the associated web site are based on the calendar year committed effective dose 
equivalent (CEDE) from intakes of radionuclides in the year of measurement projected 
over 70 years (details of methodologies can be found in Appendix 3, Daniels et al., 2006). 
Dose equivalent is given in units of rem, the conventional units used by federal and state 
agencies in the United States. The SI unit of dose equivalent is the joule per kilogram or 
 10 
sievert (Sv). Doses from exposure to environmental radioactivity (natural or manmade) 
are normally expressed as 1/1000th of the base unit, i.e., in millirem (mrem) or millisievert 
(mSv). 1 mSv is equal to 100 mrem.  
INFORMATION NOTE 
We have recently updated our methodologies for computing doses from the whole body 
counting and plutonium urinalysis programs (refer to the Technical Basis Document, 
Daniels et al., 2006). This new methodology uses a 50 y dose commitment and complies 
more fully with ICRP methodology. The algorithms developed to allow users to compute 
doses directly from the measurement data made available on the web site are also 
consistent with this new methodology.  
Doses Delivered to the Utrōk Population Group and Other Marshall Islanders from 
Internally Deposited Cesium-137 
The individual (de-identified) measurement data developed under the whole body 
counting program for the Utrōk Atoll population group as well as for other Marshall 
Islanders (excludes residents living on Enewetak Atoll and the Rongelap Atoll 
resettlement workers) are tabulated in Appendix I, TABLE 1 & 2, respectively. 
The frequency distribution of the committed effective dose equivalent received by 
program volunteers (2003-2004) from exposure to dietary cesium-137, annualized to the 
year of measurement, is shown in Figure 5. 
The Utrōk Atoll population group has been divided into those program volunteers who 
reside on Utrōk Atoll and those who live elsewhere in the Marshall Islands, largely on 
Majuro Atoll. Similarly, the Marshall Islands population group has been divided into those 
program volunteers who reside on the southern atolls (including Majuro) and those who 
live in the northern Marshall Islands. 
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Figure 5. Frequency distribution of the committed effective dose equivalent 
for the Utrōk population group (upper graphics) in comparison to other 
program volunteers residing on Majuro Atoll or elsewhere in the Marshall 
Island (lower graphics) annualized to the year of measurement (2003-2004). 
Summary graphics for each measurement year are based on the committed 
dose received over 70 year; refer supporting documentation (Daniels et al., 
2006, Appendix 3). 
The population average committed effective dose equivalent for program volunteers living 
on Utrōk Atoll was 1.6±1.4 mrem (N = 25) and 3.0±1.8 mrem (N = 21) during 2003 and 
2004, respectively. Over the same period most people from the Utrōk population group 
who lived on Majuro Atoll (or elsewhere in the Marshall Islands) did not acquire a 
measurable body burden of cesium-137 (N= 74) (Figure 5). 
Similarly, the population average committed effective dose equivalent for program 
volunteers living elsewhere in the northern Marshall Islands was 1.0±1.3 mrem (N = 23) 
and 0.8±1.2 mrem (N = 17) during 2003 and 2004, respectively. It should be noted that 
the vast majority of these program volunteers (other than Utrōk residents) lived on Ailuk 
Atoll. Again, very few people who lived on the southern atolls (including Majuro) acquired 
a measurable whole body burden of cesium-137 (N = 220) (Figure 5). No additional 
treatment of the data according to gender and age group was deemed necessary 
because the total number of volunteers in the program is still relatively few. 
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Although the whole body burdens of cesium-137 are generally low and equate to 
annualized dose contributions of less than 5 mrem, these data do show that people living 
on Utrōk Atoll and elsewhere in the northern Marshall Islands are exposed to higher 
intakes of cesium-137 in their diets. These results are also consistent with previous 
measurements performed by the Brookhaven National Laboratory (Sun et al., 1997). 
The committed effective dose equivalent from internally deposited cesium-137 within the 
Utrōk Atoll population group as well as for other program volunteers can be compared 
with natural background doses of 140 mrem per year in the Marshall Islands and 300 
mrem per year in the United States. All program volunteers received a dose from cesium-
137 ingestion that is significantly below the annual dose criteria of 100 mrem per year, 
excluding medical irradiation, imposed in 10CFR Part 20 (NRC, 2004) for protection of 
the public. The Republic of the Marshall Islands Nuclear Claims Tribunal has adopted a 
standard for cleanup of radioactively contaminated sites in the Marshall Islands of 15 
mrem per year (EDE, Effective Dose Equivalent). With the knowledge that cesium-137 
ingestion is a major contributor to dose from exposure to residual fallout contamination in 
the Marshall Islands, data derived from the whole body counting program provides an 
direct measure of the internal doses experienced by program volunteers in comparison 
with applicable cleanup standards or guidelines. Consequently, the whole body counting 
program appears to demonstrate that residents living on Utrōk Atoll are not being 
exposed to significantly elevated levels of cesium-137 in their diets. It is, however, 
recommended that the monitoring program be continued in order to acquire data across 
all age groups and to more accurately assess potential high-end doses, especially for 
permanent residents living on Utrōk Atoll and other northern atolls including Ailuk, Mejit, 
Wotje and Likiep. 
MEASUREMENT DATA FROM THE INDIVIDUAL RADIOLOGICAL SURVEILLANCE 
PROGRAM 
Introduction | Individual Measurement Database
Introduction 
The individual (de-identified) measurements database developed for the Utrōk Atoll 
population group as well as for other Marshall Islanders (excludes residents living on 
Enewetak Atoll and the Rongelap Atoll resettlement workers) is accessible over the 
world-wide web (Figure 6, http://eed.llnl.gov/mi/); 
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Enewetak Measurem ent Data
SELECT YOUR PERSONAL ID
Rongelap Measurem ent Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Measurem ent Data Other Marshall Islander Measurem ent Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 6. Layout of the menu to access measurement data from our whole body 
counting over the world-wide web (http://eed.llnl.gov/mi/). 
Whole-body counting provides a direct measure of the total amount of cesium-137 
present in the human body at the time of measurement. The amount of cesium-137 
detected is usually reported in activity units of kilo-Becequerel (kBq), where 1 kBq equals 
1000 Bq and 1 Bq = 1 nuclear transformation per second (t s-1). 
Individual Measurement Database 
The website provides electronic access to verified whole body counting data developed 
under the Marshall Islands Radiological Surveillance Program at the Lawrence Livermore 
National Laboratory (1998-present). Please note that measurement data developed for 
the Utrōk and other Marshall Islander population groups (2003-present) incorporates 
counts from all three of our whole body counting facilities and may include people from 
other affiliations with the exception of permanent residents and resettlement workers from 
Enewetak and Rongelap Atolls. 
 14 
DOSIMETRIC DATA AND METHODOLOGY  
Introduction | Dosimetric Methodology 
Introduction 
The individual (de-identified) dosimetric database developed for the Utrōk Atoll population 
group as well as for other Marshall Islanders (excludes residents living on Enewetak Atoll 
and the Rongelap Atoll resettlement workers) is accessible over the world-wide web 
(Figure 7, http://eed.llnl.gov/mi/); 
Enewetak Dosim etric Data
SELECT YOUR PERSONAL ID
Rongelap Dosim etric  Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Dosim etricData Other Marshall Islander Dosim etric Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 7. Layout of the menu to access dosimetric data from our whole body 
counting over the world-wide web (http://eed.llnl.gov/mi/). 
In general, nuclear transformations emit energy and/or particles in the form of gamma 
rays, beta particles and alpha particles. Tissues in the human body may adsorb these 
emissions with the potential for any deposited energy to cause damage and disrupt 
biological function of cells. The general term used to quantify the extent of any health risk 
from radiation exposure is referred to as the dose. The equivalent dose is defined by the 
average absorbed dose in an organ or tissue weighed by the average quality factor for 
the type and energy of the radiation causing the dose. The effective dose equivalent (as 
applied to the whole body) is the sum of the average dose equivalent for each tissue 
weighted by tissue weighing factors. The SI unit of effective dose equivalent is the joule 
per kilogram (J kg-1), named the sievert (Sv). The conventional unit often used by federal 
and state agencies in the United States is called a rem; 1 rem = 0.01 Sv.  
Based on measurements of the internally deposited 137Cs and/or the urinary excretion of 
plutonium, an estimate can be derived for either or both radionuclides of the annual 
number of nuclear transformations (t y-1) that occurred in the body during the 
measurement year. For both radionuclides, this result is the time integral of activity in the 
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body of an individual normalized over a one-year measurement period. In addition to 
nuclear transformations occurring during the year of measurement, additional 
transformations may occur in the future due to the presence of residual activity in the 
body at the end of the measurement year. The number of transformations derived from 
the residual radioactivity is usually evaluated up to 50 y in the future (a conservative 
maximum as defined by the United States (U.S.) Environmental Protection Agency (EPA) 
for members of the public) resulting in a committed dose. Accordingly, these future 
transformations will commit additional dose to the individual according to the biological 
half-life of the radioactive element of concern. For this reason, it is considered 
appropriate and conforming with the national and international recommendations of the 
United States Environment Protection Agency (EPA) and the International Commission 
on Radiological Protection (ICRP) that this additional dose commitment be assigned to 
the year of measurement. Consequently, dose reports issued under the Marshall Islands 
Radiological Surveillance Program are based on the Committed Effective Dose 
Equivalent (CEDE). 
Dosimetric Methodology 
The calendar year dose represents the sum of radionuclide-specific, age-dependent, 
committed effective dose equivalent for each monitored radionuclide. The total calendar 
years dose is calculated over a calendar year but only applies to the sum of the 
committed dose from cesium-137 and the 50-y integrated dose from plutonium (based on 
a time integral of any whole body counting and any available plutonium bioassay 
measurements performed during that year). When only one radionuclide is measured, the 
total dose assigned in a year and the CEDE for a specific radionuclide are identical. 
When more than one radionuclide is measured, the total annual ‘calendar year’ dose is 
the sum on the CEDE for each measured radionuclide. The calendar year dose estimates 
based on whole body counting and plutonium bioassay are conservative in nature, 
especially in relation to plutonium, and is only be comparable to the internal dose 
component of the EDE standard of 15 mrem per year as adopted by the Marshall Islands 
Nuclear Claims Tribunal for cleanup and rehabilitation of radioactively contaminated sites 
(to view the full report on the dose methodology, see Daniels et al., 2006). 
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PROVIDING FOLLOWUP ON RESULTS
All volunteers participating in the Marshall Islands Radiological Surveillance Program are 
issued a preliminary copy of their dose report immediately after they receive a whole 
body count. Scientists from the Lawrence Livermore National Laboratory verify the 
measurement data and, if required, issue a revised dose report. Annualized doses of 10 
mrem or above will normally evoke a pre-determined action or investigation for the 
particular radionuclide concerned. These actions may include follow-up verification 
measurements, a dietary evaluation and/or a work history review. Below this level, default 
assumptions for assigning doses (Daniels et al., 2006) are assumed to be valid and no 
further action is taken. Data may be withheld from the website or hard copy reports while 
these investigations are on-going. Our action level is one-tenth of the investigation level 
used throughout the U.S. Department of Energy and is well below the 15 mrem per year 
standard adopted by the Republic of the Marshall Islands Nuclear Claims Tribunal for 
cleanup of radioactively contaminated sites. In addition, at the end of each calendar year, 
all program volunteers receive a final written report containing an estimate of their 
“calendar year dose” based on available data for the measurements year. 
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GLOSSARY OF TERMS 
Absorbed Dose 
The absorbed dose is the energy deposited in an organ or tissue per unit mass of 
irradiated material. The common unit for absorbed dose is the rad, which is equivalent to 
100 egs per gram of material. The international scientific community has adopted the use 
of different terms. The SI unit of absorbed dose is the joule per kilogram (J kg−1) and its 
special name is the gray (Gy). One Gy is the same as 100 rad. 
Activity 
Activity is the rate of transformation or decay of a radioactive material. The SI unit of 
activity is the reciprocal second (s−1) and its special name is the Becquerel. Federal and 
state agencies in the United States use conventional units where activity is given in 
curies (Ci); 1 Ci = 3.7 x 1010 Bq. 
Alpha Particles 
Alpha particles are one of the primary types of radiation associated with radioactivity and 
exist as energetic nuclei of helium atoms, consisting of two protons and two neutrons. 
Alpha rays are heavy, slow moving, charged particles that travel only one or two inches in 
air, and can be stopped by a piece of paper or the outer dead layer of human skin.  
Background Radiation  
The average person in the United States receives about 3.6 mSv (360 mrem) of ionizing 
radiation every year. About 3.0 mSv (300 mrem) per year comes from natural 
background radiation including cosmic radiation, radiation emitted by naturally occurring 
radionuclides in air, water, soil and rock, and radiation emitted by natural radionuclides 
deposited in tissues of organs; and  about (0.6 mSv) 60 mrem from man-made sources 
such as exposures to diagnostic X-rays and consumer products (e.g., from smoking 
tobacco). The general worldwide contribution from radioactive fallout contamination is 
<0.3% of the average total annual dose. Exposures to natural background radiation vary 
depending on the geographic area, diet and other factors such as the composition of 
materials used in the construction of homes. The natural background radiation dose in 
the Marshall Islands is around 1.4 mSv (140 mrem) per year and is significantly less than 
what most people receive around the world. 
Baseline 
We have all been exposed to some level of worldwide fallout contamination. In the United 
States, the general population receives up to 0.015 mSv (1.5 mrem) or about 0.3% of the 
average total annual dose from exposure to worldwide fallout contamination from 
atmospheric nuclear weapons testing and about 0.005 (0.5 mrem) or about 0.1% of the 
average total annual dose from operations related nuclear power generation. Similarly, 
people living in the Marshall Islands will have very small quantities of internally deposited 
fallout radionuclides such as cesium-137, strontium-90 and plutonium in their bodies from 
worldwide contamination of food, air, water and soil. Assessments of possible increases 
in radiation exposure from elevated levels of fallout contamination in the northern 
Marshall Islands can only be made on the basis of comparisons with residual systematic 
burdens of radionuclides acquired from previous exposures to global fallout 
contamination. Under the Marshall Islands Radiological Surveillance Program, efforts are 
being made to improve on the reliability of measurements of background urinary 
excretion rates of plutonium from Marshallese populations against which the results of 
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future bioassay measurements can be compared to accurately assess the impacts of 
resettlement on radiation exposure and dose. 
Becquerel (Bq) 
A Becquerel (abbreviated as Bq) is the International System (SI) unit for activity of 
radioactive material. One Bq of radioactive material is that amount of material in which 
one atom is transformed or undergoes 1 disintegration every second. Whole body 
counting and plutonium bioassay measurements are usually reported in activity units of 
kBq (kiloBecquerel) (1000 x 1 Bq) and μBq (microBecquerel) (1×10−6 x 1 Bq), 
respectively. 
Biokinectic 
The word ‘biokinectic’ is used here to describe the adsorption (uptake), distribution and 
retention of elements in humans.   
Calibration 
Calibration is the process of adjusting or determining the response or reading of an 
instrument to a standard.   
Committed Dose Equivalent 
Committed dose equivalent is the time integral of the dose-equivalent rate in a particular 
tissue that will be received by an individual following an intake of radioactive material into 
the body by inhalation, ingestion or dermal absorption. For adults the committed dose is 
usually the dose received over 50 years. For children, the committed dose is usually 
calculated from the age of intake to age 70 years. For these age groups the term 
‘integrated dose equivalent’ is used. 
Committed Effective Dose Equivalent (CEDE) 
The committed effective dose equivalent is the committed dose equivalents to various 
tissues or organ in the body each multiplied by an appropriate tissue-weighing factor and 
then summed. The conventional unit for committed effective dose equivalence (CEDE) 
used by federal and state agencies within the United States is the rem. The international 
scientific (SI) unit of committed effective dose equivalent is called a sievert (Sv). One Sv 
is the same as 100 rem. 
Critical Level (Lc) 
The critical level is the amount of a count or final measurement of a quantity of an analyte 
at or above which a decision is made that the analyte is definitely present (Lc ≈ MDA/2). 
Default Assumptions (used in assignment of dose) 
The largest dose contributions attributable to exposure to residual nuclear fallout 
contamination in the Marshall Islands result from either internal exposure from intakes of 
radionuclides through ingestion, inhalation and/or absorption through the skin or external 
exposure from radionuclides distributed in the soil. External exposure rates can be 
measured directly using instrument surveys of the radiation field. The assignment of dose 
to internally deposited radionuclides is much more complicated. Biokinectic and 
dosimetric models developed by the International Commission on Radiological Protection 
(ICRP) are used to convert whole body burdens (from whole body counting or from in 
vitro bioassay tests such as urinalysis) into dose. In the case of a chronic exposure, 
organ and body burdens continue to build up over time until a steady state is reached 
where losses due to decay and excretion are balanced by intake and absorption. 
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Cesium-137 has an effective half-life in an adult of about 110 days, and under chronic 
exposure conditions reaches a maximal dose contribution after about 2 years. By 
contrast, plutonium absorbed from the gastrointestinal or respiratory tract enters the 
blood stream and deposits in liver and bone with an effective half-life of 20 to 50 years. 
Only a small fraction of plutonium entering the blood stream is excreted in urine with the 
long-term excretion rate approaching 2 x 10−5 of the systemic body burden per day. 
Knowledge of excretion rates and time of exposure are important when interpreting 
urinalysis data. A more detailed discussion of the dose calculation methodology is given 
elsewhere (see under Daniels et al., 2006). 
Direct bioassay 
The measurements of radioactive material in the human body utilizing instrumentation 
that detects radiation emitted from radioactive material in the body (synonymous with in 
vivo measurements).  
Dose Assessment 
The scientific process used to determine radiation dose and uncertainty in the dose.  
Dose Equivalent 
The dose equivalent is the adsorbed dose at a point in tissue multiplied by a biological 
effectiveness factor or quality factor for the particular types of radiation to cause 
biological damage. The conventional unit of dose equivalents used by federal and state 
agencies in the United States is the rem. A dose of 100 rem to an adult normally 
produces some clinical signs of radiation sickness and requires hospitalization. The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
Effective Dose Equivalent 
The effective dose equivalent for the whole body is the sum of dose-equivalents for 
various organs in the body weighted to account for different sensitivities of the organs to 
radiation. It includes the dose from radiation sources internal and/or external to the body.  
The effective dose equivalent is usually expressed in units of millirem (mrem). The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
External Dose or Exposure 
That portion of the dose equivalent received from radiation sources outside the human 
body. 
Fission Track Analysis 
During neutron irradiation heavy nuclei such as uranium and plutonium undergo nuclear 
fission with release of large fission fragments. This property has led to the development 
of a number of measurement techniques such as delayed neutron activation analysis and 
fission track analysis. Fission track analysis is a measurement technique commonly 
employed in plutonium urinalysis (bioassay) monitoring programs. Urine samples are 
chemically treated to remove plutonium. The plutonium is then mounted in contact with a 
special plastic or quartz slide known as solid-state nuclear track detector (SSNTD). The 
slide along with the sample is then irradiated in a reactor where neutron-induced fission 
of plutonium-239 (or uranium-235) causes emission of energetic fission fragments. Some 
of the fragments penetrate into the SSNTD damaging the integrity of the material before 
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coming to rest. The SSNTD is separated from the sample and chemically etched to 
expose the damaged areas (known as fission tracks) on the detector surface. The fission 
tracks are then counted under an optical microscope. The amount of plutonium (and/or 
uranium) present in the sample is a function of the total number of tracks and the neutron 
flux. 
Gamma-rays 
Gamma-rays are electromagnetic waves produced by spontaneous decay of radioactive 
elements during de-excitation of an atomic nucleus. Sunlight also consists of 
electromagnetic waves but gamma-rays have a shorter wavelength and much higher 
energy. High-energy gamma-rays such as those produced by decay of cesium-137 may 
penetrate deeply into the body and affect cells. Gamma-rays from a cobalt-60 source are 
often used for cancer radiotherapy. 
High-End Health Risk 
High-end health risk is used here under the context that it refers to the maximally 
exposed individuals in a population. 
In Vito 
In vitro measurements are synonymous with indirect bioassay techniques, such as 
plutonium urinalysis. 
In Vivo 
In vivo measurements are synonymous with bioassay techniques, such as whole body 
counting.  
Indirect bioassay 
In direct bioassay are measurements used to determine the presence of and/or the 
amount of a radioactive material in the excreta, urine or in other biological materials 
removed from the body (synonymous with in vitro measurements). 
Individual 
An individual is any human being. 
Internal Dose or Exposure  
The internal dose is that portion of the dose equivalent received from radiation sources 
inside the human body. 
Isotope 
Atoms with the same number of protons but different numbers of neutrons are called 
isotopes of that element. We identify different isotopes by appending the total number of 
nucleons (the total number of proton plus neutrons in the nucleus of an atom) to the 
name of the element, e.g., cesium-137. Isotopes are usually written in an abbreviated 
form using the chemical symbol of the element. Two examples include 137Cs for cesium-
137 and 239Pu for plutonium-239.   
Minimum Detectable Amount (MDA) 
The minimum detectable amount (MDA) is the smallest activity or mass of an analyte in a 
sample or person that can be detected with an acceptable level of uncertainty. 
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Quality Assurance 
All those planned and systematic actions necessary to provide adequate confidence that 
an analysis, measurement or surveillance program will perform satisfactorily. 
Quality Control 
Quality Control is defined as those actions taken to control the attributes of a analytical 
process, system or facility according to predetermined quality requirements. 
Radiation Dose (or mrem)
A generic term to describe the amount of radiation a person receives. Dose is measured 
in units of thousands of a roentegen equivalent man (rem) (called the millirem). The 
conventional unit used by federal and state agencies in the United States is the millirem 
(mrem). Dose is a general term used to assist in the management of exposure to 
radiation. The common international scientific (SI) unit for dose is the millisievert (mSv). 
One mSv is the same as 100 mrem. 
Radioactivity 
A natural and spontaneous process by which unstable atoms of an element emit energy 
and/or particles from their nuclei and, thus change (or decay) to atoms of a different 
element or a different state of the same element. 
Radiological Monitoring 
Radiological monitoring is the process of measuring radiation levels or individual doses, 
and the use of the results to assess radiological hazards or potential and actual doses 
resulting from exposures to ionizing radiation. 
Remediation 
Remediation is the actions taken to reduce risks to human health or the environment 
posed by the presence of radioactive or hazardous materials. 
Risk 
The probability of harm from the presence of radionuclides or hazardous materials taking 
into account (1) the probability of occurrences or events that could lead to an exposure, 
(2) probability that individual or populations would be exposed to radioactive or 
hazardous materials and the magnitude of such exposures, and (3) the probability that an 
exposure would produce a response.  
Validation 
Validation refers to the process of defining the method capability and determining 
whether it can be properly applied as intended. 
Whole Body 
For the purposes of external exposure includes the head, trunk, the arms above and 
including the elbow, and legs above and including the knee. 
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Table 1. Whole body count data for the Utrōk Atoll population group (2003-2004). 
137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
UT00002 Adult Male 2003-07-21 0.00 ± 0.00 0.11 
UT00002 Adult Male 2004-02-28 0.00 ± 0.00 0.07 
UT00003 Adult Female 2003-07-21 0.00 ± 0.00 0.11 
UT00004 Adult Male 2003-07-21 0.00 ± 0.00 0.11 
UT00005 Adult Female 2003-07-21 0.00 ± 0.00 0.10 
UT00006 Adult Female 2003-07-22 0.00 ± 0.00 0.11 
UT00006 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
UT00007 Adult Male 2003-07-23 0.00 ± 0.00 0.11 
UT00007 Adult Male 2004-08-31 0.00 ± 0.00 3.28 
UT00008 Adult Male 2003-07-23 0.61 ± 0.03 0.18 
UT00009 Adult Female 2003-07-23 0.38 ± 0.02 0.18 
UT00009 Adult Female 2004-05-14 0.00 ± 0.00 0.12 
UT00010 Pre-Teen Female 2003-07-23 0.00 ± 0.00 0.10 
UT00011 Adult Female 2003-07-24 0.00 ± 0.00 0.10 
UT00012 Adult Male 2003-07-24 0.00 ± 0.00 0.10 
UT00013 Teenager Female 2003-07-28 0.00 ± 0.00 0.10 
UT00014 Adult Male 2003-07-28 0.00 ± 0.00 0.11 
UT00015 Adult Female 2003-07-28 0.00 ± 0.00 0.10 
UT00016 Adult Male 2003-07-29 0.00 ± 0.00 0.10 
UT00017 Adult Female 2003-07-29 0.00 ± 0.00 0.10 
UT00018 Adult Male 2003-07-30 0.00 ± 0.00 0.10 
UT00019 Adult Female 2003-07-30 0.00 ± 0.00 0.10 
UT00019 Adult Female 2004-08-30 0.00 ± 0.00 3.23 
UT00020 Adult Female 2003-07-30 0.00 ± 0.00 0.10 
UT00020 Adult Female 2004-10-21 0.00 ± 0.00 3.05 
UT00021 Adult Female 2003-08-04 0.00 ± 0.00 0.10 
UT00022 Adult Female 2003-08-04 0.00 ± 0.00 0.10 
UT00023 Adult Male 2003-08-06 0.00 ± 0.00 0.10 
UT00023 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
UT00024 Adult Female 2003-08-01 0.00 ± 0.00 0.10 
UT00025 Adult Male 2003-08-01 0.00 ± 0.00 0.10 
UT00026 Adult Female 2003-08-01 0.00 ± 0.00 0.10 
UT00027 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
UT00027 Adult Female 2003-11-26 0.00 ± 0.00 0.10 
UT00028 Adult Female 2003-08-08 0.00 ± 0.00 0.11 
UT00029 Adult Male 2003-08-08 1.20 ± 0.04 0.19 
UT00030 Adult Female 2003-08-13 0.00 ± 0.00 0.11 
UT00031 Adult Male 2003-08-13 0.17 ± 0.02 0.18 
UT00031 Adult Male 2004-04-20 0.00 ± 0.00 3.51 
UT00032 Adult Male 2003-08-13 0.00 ± 0.00 0.10 
UT00033 Adult Male 2003-08-13 0.00 ± 0.00 0.11 
UT00034 Adult Male 2003-08-13 0.56 ± 0.03 0.17 
UT00035 Adult Female 2003-08-14 0.00 ± 0.00 0.10 
UT00036 Adult Male 2003-08-14 0.00 ± 0.00 0.10 
UT00037 Adult Female 2003-08-14 0.00 ± 0.00 0.10 
UT00038 Adult Female 2003-08-14 0.00 ± 0.00 0.10 
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UT00039 Adult Female 2003-08-14 0.30 ± 0.02 0.17 
UT00040 Adult Female 2003-08-14 0.00 ± 0.00 0.10 
UT00041 Adult Female 2003-08-15 0.00 ± 0.00 0.10 
UT00041 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
UT00042 Adult Female 2003-08-15 0.00 ± 0.00 0.11 
UT00043 Adult Male 2003-08-15 0.28 ± 0.02 0.17 
UT00044 Adult Female 2003-08-18 0.32 ± 0.02 0.17 
UT00045 Adult Male 2003-08-18 0.42 ± 0.02 0.17 
UT00046 Adult Female 2003-08-19 0.00 ± 0.00 0.10 
UT00047 Pre-Teen Female 2003-08-20 0.00 ± 0.00 0.11 
UT00048 Pre-Teen Male 2003-08-20 0.00 ± 0.00 0.10 
UT00049 Adult Female 2003-08-22 0.00 ± 0.00 0.10 
UT00050 Adult Female 2003-09-02 0.00 ± 0.00 0.10 
UT00051 Adult Male 2003-09-02 0.00 ± 0.00 0.10 
UT00052 Teenager Female 2003-10-09 0.18 ± 0.02 0.14 
UT00053 Adult Female 2003-10-14 0.21 ± 0.02 0.15 
UT00054 Adult Female 2003-10-14 0.46 ± 0.03 0.19 
UT00055 Adult Male 2003-10-16 0.15 ± 0.02 0.15 
UT00056 Adult Female 2003-11-03 0.00 ± 0.00 0.11 
UT00056 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
UT00057 Adult Male 2003-11-07 0.41 ± 0.03 0.18 
UT00058 Adult Male 2003-11-07 0.34 ± 0.03 0.18 
UT00058 Adult Male 2004-11-03 0.77 ± 0.08 0.33 
UT00059 Adult Male 2003-11-07 0.44 ± 0.03 0.19 
UT00060 Adult Male 2003-11-07 0.63 ± 0.03 0.18 
UT00060 Adult Male 2004-12-13 1.06 ± 0.07 0.29 
UT00061 Adult Male 2003-11-07 0.24 ± 0.02 0.18 
UT00061 Adult Male 2004-12-01 0.20 ± 0.07 0.33 
UT00062 Adult Male 2003-11-07 0.29 ± 0.02 0.18 
UT00063 Adult Male 2003-11-11 0.15 ± 0.02 0.14 
UT00064 Adult Male 2003-11-11 0.00 ± 0.00 0.11 
UT00065 Adult Female 2003-11-13 0.47 ± 0.03 0.18 
UT00066 Adult Female 2003-11-13 0.33 ± 0.03 0.18 
UT00066 Adult Female 2004-11-03 0.60 ± 0.07 0.32 
UT00067 Adult Female 2003-11-26 0.12 ± 0.02 0.17 
UT00067 Adult Female 2004-01-23 0.00 ± 0.00 0.11 
UT00068 Adult Male 2003-12-09 0.00 ± 0.00 0.11 
UT00068 Adult Male 2004-09-16 0.00 ± 0.00 0.11 
UT00069 Adult Male 2004-01-22 0.17 ± 0.02 0.13 
UT00069 Adult Male 2004-04-28 0.09 ± 0.04 0.19 
UT00070 Adult Male 2004-02-04 0.40 ± 0.03 0.18 
UT00071 Adult Female 2004-02-26 0.07 ± 0.04 0.19 
UT00072 Adult Female 2004-02-26 0.00 ± 0.00 0.10 
UT00072 Adult Female 2004-10-29 0.00 ± 0.00 0.11 
UT00073 Adult Female 2004-02-27 0.00 ± 0.00 0.09 
UT00074 Adult Male 2004-04-28 0.35 ± 0.07 0.32 
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UT00075 Adult Male 2004-04-28 0.00 ± 0.00 0.11 
UT00076 Adult Female 2004-05-14 0.72 ± 0.07 0.30 
UT00077 Adult Female 2004-05-14 0.41 ± 0.07 0.33 
UT00078 Adult Female 2004-07-20 0.00 ± 0.00 0.11 
UT00079 Adult Male 2004-07-08 0.89 ± 0.08 0.35 
UT00080 Adult Male 2004-07-22 0.97 ± 0.08 0.34 
UT00081 Adult Male 2004-07-22 0.98 ± 0.08 0.32 
UT00082 Adult Male 2004-07-23 0.12 ± 0.05 0.21 
UT00083 Teenager Male 2004-07-23 0.70 ± 0.08 0.33 
UT00084 Teenager Male 2004-07-24 0.40 ± 0.07 0.33 
UT00085 Teenager Male 2004-07-24 0.00 ± 0.00 0.12 
UT00086 Teenager Female 2004-08-06 0.48 ± 0.08 0.34 
UT00087 Adult Male 2004-08-10 0.00 ± 0.00 0.11 
UT00088 Adult Male 2004-08-10 0.53 ± 0.08 0.35 
UT00089 Adult Male 2004-08-10 0.41 ± 0.08 0.34 
UT00090 Adult Male 2004-08-10 0.18 ± 0.05 0.25 
UT00091 Adult Male 2004-08-10 0.00 ± 0.00 0.11 
UT00092 Adult Male 2004-08-31 0.57 ± 0.07 0.33 
UT00093 Adult Female 2004-09-02 0.00 ± 0.00 0.11 
UT00094 Adult Male 2004-09-02 0.00 ± 0.00 0.11 
UT00095 Adult Female 2004-09-08 0.00 ± 0.00 0.11 
UT00096 Adult Female 2004-09-08 0.00 ± 0.00 0.11 
UT00097 Adult Female 2004-09-13 0.00 ± 0.00 0.11 
UT00098 Adult Female 2004-09-13 0.00 ± 0.00 0.11 
UT00099 Adult Male 2004-09-16 0.00 ± 0.00 0.11 
UT00100 Adult Female 2004-10-05 0.00 ± 0.00 0.11 
UT00101 Adult Male 2004-10-11 0.00 ± 0.00 0.11 
UT00102 Adult Female 2004-10-21 0.00 ± 0.00 0.12 
UT00103 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
UT00104 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
UT00105 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
UT00106 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00107 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00108 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00109 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00110 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00111 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00112 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
UT00113 Adult Male 2004-10-26 0.83 ± 0.08 0.34 
UT00114 Adult Male 2004-10-26 0.87 ± 0.08 0.35 
UT00115 Adult Male 2004-10-26 1.39 ± 0.10 0.38 
UT00116 Adult Female 2004-11-29 0.76 ± 0.07 0.31 
UT00117 Adult Female 2004-12-01 0.00 ± 0.00 0.11 
UT00118 Adult Male 2004-12-01 0.00 ± 0.00 0.11 
UT00119 Adult Male 2004-12-01 0.00 ± 0.00 0.11 
UT00120 Adult Female 2004-12-01 0.00 ± 0.00 0.11 
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UT00121 Adult Female 2004-12-02 0.00 ± 0.00 0.11 
UT00122 Adult Female 2004-12-23 0.00 ± 0.00 0.11 
UT00126 Adult Female 2004-12-09 0.25 ± 0.07 0.33 
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MI00003 Adult Male 2003-07-21 0.00 ± 0.00 0.09 
MI00003 Adult Male 2003-11-04 0.00 ± 0.00 0.11 
MI00003 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00003 Adult Male 2004-02-10 0.00 ± 0.00 0.11 
MI00003 Adult Male 2004-02-25 0.00 ± 0.00 0.10 
MI00003 Adult Male 2004-04-13 0.00 ± 0.00 0.11 
MI00003 Adult Male 2004-12-09 0.00 ± 0.00 0.11 
MI00006 Adult Male 2003-07-21 0.00 ± 0.00 0.11 
MI00007 Adult Female 2003-07-19 0.00 ± 0.00 0.11 
MI00008 Adult Female 2003-07-22 0.00 ± 0.00 0.10 
MI00009 Adult Female 2003-07-22 0.00 ± 0.00 0.11 
MI00010 Adult Male 2003-07-22 0.00 ± 0.00 0.11 
MI00011 Adult Female 2003-07-22 0.00 ± 0.00 0.11 
MI00012 Adult Female 2003-07-22 0.00 ± 0.00 0.11 
MI00013 Adult Female 2003-07-22 0.00 ± 0.00 0.11 
MI00014 Adult Male 2003-07-22 0.00 ± 0.00 0.11 
MI00015 Adult Male 2003-07-22 0.00 ± 0.00 0.11 
MI00016 Adult Male 2003-07-23 0.00 ± 0.00 0.11 
MI00017 Adult Male 2003-07-23 0.00 ± 0.00 0.10 
MI00018 Adult Male 2003-07-23 0.00 ± 0.00 0.10 
MI00019 Adult Male 2003-07-23 0.00 ± 0.00 0.10 
MI00020 Adult Male 2004-05-10 0.00 ± 0.00 0.11 
MI00021 Adult Male 2003-07-24 0.00 ± 0.00 0.10 
MI00022 Adult Male 2003-07-24 0.00 ± 0.00 0.10 
MI00023 Adult Male 2003-07-24 0.00 ± 0.00 0.11 
MI00024 Adult Female 2003-07-24 0.00 ± 0.00 0.10 
MI00025 Adult Female 2003-07-24 0.00 ± 0.00 0.11 
MI00026 Teenager Female 2003-07-25 0.00 ± 0.00 0.11 
MI00027 Adult Female 2003-07-25 0.00 ± 0.00 0.10 
MI00028 Adult Female 2003-07-25 0.00 ± 0.00 0.11 
MI00029 Adult Male 2003-07-25 0.00 ± 0.00 0.10 
MI00030 Adult Female 2003-07-25 0.00 ± 0.00 0.10 
MI00031 Adult Male 2003-07-25 0.00 ± 0.00 0.10 
MI00032 Adult Male 2003-08-05 0.00 ± 0.00 0.11 
MI00033 Adult Female 2003-08-05 0.00 ± 0.00 0.10 
MI00034 Adult Male 2003-08-06 0.00 ± 0.00 0.11 
MI00035 Adult Male 2003-08-06 0.38 ± 0.02 0.18 
MI00036 Adult Female 2003-08-06 0.00 ± 0.00 0.12 
MI00037 Adult Male 2003-08-06 0.48 ± 0.03 0.18 
MI00038 Adult Female 2003-08-06 0.00 ± 0.00 0.10 
MI00039 Adult Male 2003-08-06 0.00 ± 0.00 0.11 
MI00040 Adult Male 2003-08-06 0.00 ± 0.00 0.10 
MI00041 Adult Male 2003-08-06 0.11 ± 0.02 0.17 
MI00042 Adult Male 2003-08-06 0.00 ± 0.00 0.10 
MI00043 Adult Male 2003-08-07 0.92 ± 0.03 0.18 
MI00044 Adult Male 2003-08-07 0.34 ± 0.02 0.17 
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MI00045 Adult Male 2003-08-07 0.00 ± 0.00 0.10 
MI00046 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
MI00047 Adult Male 2003-08-07 0.00 ± 0.00 0.10 
MI00048 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
MI00049 Adult Female 2003-08-07 0.00 ± 0.00 0.11 
MI00050 Adult Female 2003-08-07 0.00 ± 0.00 0.11 
MI00051 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
MI00052 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
MI00053 Adult Male 2003-08-07 0.00 ± 0.00 0.10 
MI00054 Adult Female 2003-08-07 0.00 ± 0.00 0.10 
MI00055 Adult Male 2003-08-07 0.00 ± 0.00 0.10 
MI00056 Adult Male 2003-08-07 0.00 ± 0.00 0.10 
MI00057 Adult Male 2003-08-08 0.00 ± 0.00 0.10 
MI00058 Adult Female 2003-08-08 0.23 ± 0.02 0.18 
MI00059 Adult Female 2003-08-08 0.00 ± 0.00 0.10 
MI00060 Adult Male 2003-08-08 0.00 ± 0.00 0.10 
MI00061 Adult Male 2003-08-11 0.00 ± 0.00 0.10 
MI00062 Adult Male 2003-08-11 0.00 ± 0.00 0.10 
MI00063 Adult Female 2003-08-11 0.00 ± 0.00 0.10 
MI00064 Adult Female 2003-08-11 0.00 ± 0.00 0.10 
MI00065 Adult Male 2003-08-11 0.00 ± 0.00 0.10 
MI00066 Adult Female 2003-08-11 0.00 ± 0.00 0.10 
MI00067 Adult Female 2003-08-11 0.00 ± 0.00 0.10 
MI00068 Adult Male 2003-08-13 0.00 ± 0.00 0.10 
MI00069 Adult Male 2003-08-13 0.00 ± 0.00 0.10 
MI00070 Adult Male 2003-08-13 0.00 ± 0.00 0.10 
MI00071 Adult Male 2003-08-14 0.00 ± 0.00 0.11 
MI00072 Adult Female 2003-08-14 0.00 ± 0.00 0.11 
MI00073 Adult Female 2003-08-18 0.00 ± 0.00 0.10 
MI00074 Adult Male 2003-08-18 0.00 ± 0.00 0.10 
MI00075 Adult Female 2003-08-18 0.00 ± 0.00 0.10 
MI00076 Adult Female 2003-08-18 0.00 ± 0.00 0.10 
MI00076 Adult Female 2004-10-11 0.00 ± 0.00 0.11 
MI00077 Adult Female 2003-08-18 0.00 ± 0.00 0.10 
MI00078 Adult Male 2003-08-18 0.00 ± 0.00 0.10 
MI00079 Adult Male 2003-08-19 0.00 ± 0.00 0.10 
MI00080 Adult Male 2003-08-19 0.00 ± 0.00 0.11 
MI00081 Adult Female 2003-08-19 0.00 ± 0.00 0.10 
MI00082 Adult Female 2003-08-19 0.43 ± 0.02 0.17 
MI00083 Adult Female 2003-08-22 0.00 ± 0.00 0.10 
MI00084 Adult Male 2003-08-28 0.00 ± 0.00 0.11 
MI00085 Adult Male 2003-09-01 0.00 ± 0.00 0.10 
MI00086 Adult Male 2003-09-01 0.00 ± 0.00 0.10 
MI00087 Adult Female 2003-09-01 0.00 ± 0.00 0.10 
MI00088 Adult Female 2003-09-01 0.00 ± 0.00 0.10 
MI00089 Adult Male 2003-09-01 0.00 ± 0.00 0.10 
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MI00090 Adult Male 2003-09-01 0.00 ± 0.00 0.10 
MI00091 Adult Male 2003-09-03 0.00 ± 0.00 0.10 
MI00092 Adult Female 2003-10-06 0.00 ± 0.00 0.11 
MI00093 Adult Female 2003-10-06 0.00 ± 0.00 0.12 
MI00093 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
MI00094 Adult Female 2003-10-09 0.00 ± 0.00 0.09 
MI00095 Adult Female 2003-10-31 0.00 ± 0.00 0.11 
MI00096 Adult Female 2003-10-31 0.11 ± 0.02 0.18 
MI00097 Adult Male 2003-10-31 0.35 ± 0.02 0.18 
MI00098 Adult Female 2003-10-31 0.17 ± 0.02 0.18 
MI00099 Adult Female 2003-10-31 0.00 ± 0.00 0.11 
MI00100 Adult Male 2003-10-31 0.00 ± 0.00 0.11 
MI00101 Adult Female 2003-11-03 0.00 ± 0.00 0.11 
MI00102 Adult Male 2003-11-04 0.00 ± 0.00 0.11 
MI00102 Adult Male 2003-11-25 0.52 ± 0.03 0.18 
MI00103 Adult Male 2003-11-04 0.00 ± 0.00 0.10 
MI00105 Adult Male 2003-11-05 0.00 ± 0.00 0.10 
MI00106 Adult Female 2003-11-06 0.36 ± 0.03 0.18 
MI00107 Adult Male 2003-11-06 0.00 ± 0.00 0.11 
MI00108 Adult Female 2003-11-07 0.00 ± 0.00 0.11 
MI00109 Adult Male 2003-11-07 0.22 ± 0.02 0.18 
MI00109 Adult Male 2003-11-24 0.20 ± 0.02 0.18 
MI00110 Adult Male 2003-11-12 0.00 ± 0.00 0.11 
MI00111 Adult Male 2003-11-12 0.00 ± 0.00 0.11 
MI00112 Adult Female 2003-11-19 0.00 ± 0.00 0.10 
MI00115 Adult Male 2003-11-21 0.00 ± 0.00 0.11 
MI00116 Adult Male 2003-11-21 0.17 ± 0.03 0.18 
MI00117 Adult Male 2003-11-21 0.00 ± 0.00 0.11 
MI00119 Adult Female 2003-11-25 0.40 ± 0.03 0.18 
MI00120 Adult Female 2003-11-25 0.00 ± 0.00 0.11 
MI00121 Adult Male 2003-11-26 0.00 ± 0.00 0.11 
MI00122 Adult Female 2003-11-26 0.00 ± 0.00 0.11 
MI00123 Adult Male 2004-11-26 0.00 ± 0.00 0.11 
MI00124 Adult Male 2003-12-01 0.00 ± 0.00 0.11 
MI00125 Adult Male 2003-11-28 0.00 ± 0.00 0.11 
MI00126 Adult Male 2003-12-01 0.00 ± 0.00 0.11 
MI00127 Adult Male 2003-12-01 0.00 ± 0.00 0.11 
MI00129 Adult Male 2003-12-02 0.00 ± 0.00 0.11 
MI00130 Adult Male 2003-12-02 0.23 ± 0.02 0.18 
MI00131 Adult Female 2003-12-04 0.00 ± 0.00 0.11 
MI00132 Teenager Female 2003-12-04 0.00 ± 0.00 0.10 
MI00133 Adult Female 2003-12-04 0.00 ± 0.00 0.11 
MI00134 Adult Male 2003-12-17 0.00 ± 0.00 0.11 
MI00135 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00136 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00138 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
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MI00139 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00140 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00141 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
MI00142 Adult Male 2004-01-07 0.00 ± 0.00 0.11 
MI00143 Adult Male 2004-01-08 0.00 ± 0.00 0.11 
MI00144 Adult Female 2004-01-09 0.00 ± 0.00 0.11 
MI00145 Adult Male 2004-01-09 0.00 ± 0.00 0.11 
MI00146 Adult Male 2004-01-09 0.00 ± 0.00 0.11 
MI00147 Adult Male 2004-01-09 0.00 ± 0.00 0.11 
MI00149 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00150 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00151 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00152 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00153 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00154 Adult Male 2004-01-20 0.00 ± 0.00 0.11 
MI00155 Adult Female 2004-01-20 0.00 ± 0.00 0.11 
MI00156 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00157 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00158 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00159 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00160 Adult Male 2004-01-21 0.00 ± 0.00 0.20 
MI00160 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00161 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00162 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00163 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00164 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00165 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00166 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00167 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00168 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00169 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00170 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00171 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00172 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00173 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00174 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00175 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00176 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00177 Adult Male 2004-01-21 0.00 ± 0.00 0.11 
MI00178 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00179 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00180 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00181 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00182 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00183 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00184 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
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MI00185 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00186 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00187 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00188 Adult Male 2004-01-22 0.00 ± 0.00 0.11 
MI00189 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00190 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00191 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00192 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00193 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00194 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00195 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00196 Adult Male 2004-01-23 0.00 ± 0.00 0.11 
MI00197 Adult Male 2004-01-27 0.00 ± 0.00 0.11 
MI00198 Adult Male 2004-01-27 0.00 ± 0.00 0.10 
MI00199 Adult Male 2004-01-27 0.00 ± 0.00 0.10 
MI00200 Adult Male 2004-01-27 0.00 ± 0.00 0.11 
MI00201 Adult Male 2004-02-10 0.00 ± 0.00 0.11 
MI00202 Adult Female 2004-02-12 0.00 ± 0.00 0.11 
MI00203 Adult Male 2004-02-12 0.00 ± 0.00 0.11 
MI00204 Adult Male 2004-02-18 0.00 ± 0.00 0.11 
MI00205 Adult Male 2004-02-18 0.10 ± 0.02 0.17 
MI00206 Adult Male 2004-04-19 0.27 ± 0.07 0.32 
MI00208 Adult Male 2004-05-07 0.00 ± 0.00 0.11 
MI00209 Adult Male 2004-05-21 0.00 ± 0.00 0.11 
MI00210 Adult Female 2004-07-13 0.00 ± 0.00 0.11 
MI00211 Adult Female 2004-07-13 0.00 ± 0.00 0.11 
MI00212 Adult Male 2004-07-13 0.00 ± 0.00 0.11 
MI00212 Adult Male 2004-08-10 0.00 ± 0.00 0.11 
MI00213 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
MI00215 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
MI00216 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
MI00217 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
MI00218 Adult Male 2004-07-15 0.00 ± 0.00 0.11 
MI00220 Adult Female 2004-08-05 0.00 ± 0.00 0.11 
MI00221 Teenager Female 2004-07-20 0.00 ± 0.00 0.11 
MI00222 Adult Male 2004-07-21 0.00 ± 0.00 0.11 
MI00223 Adult Male 2004-07-21 0.00 ± 0.00 0.11 
MI00224 Adult Male 2004-07-21 0.00 ± 0.00 0.11 
MI00226 Adult Female 2004-07-22 0.00 ± 0.00 0.11 
MI00227 Adult Male 2004-07-23 0.00 ± 0.00 0.11 
MI00228 Teenager Female 2004-07-26 0.00 ± 0.00 0.11 
MI00229 Adult Female 2004-07-26 0.00 ± 0.00 0.11 
MI00230 Adult Female 2004-07-26 0.00 ± 0.00 0.11 
MI00231 Adult Male 2004-07-26 0.00 ± 0.00 0.11 
MI00232 Adult Male 2004-07-27 0.00 ± 0.00 0.12 
MI00233 Adult Male 2004-07-28 0.00 ± 0.00 0.11 
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MI00234 Adult Male 2004-07-29 0.00 ± 0.00 0.11 
MI00235 Adult Male 2004-08-05 0.00 ± 0.00 0.11 
MI00236 Adult Female 2004-08-06 0.00 ± 0.00 0.11 
MI00237 Adult Male 2004-08-09 0.00 ± 0.00 0.11 
MI00238 Adult Male 2004-08-13 0.10 ± 0.05 0.21 
MI00239 Adult Female 2004-08-16 0.00 ± 0.00 0.11 
MI00240 Adult Female 2004-08-17 0.09 ± 0.05 0.22 
MI00240 Adult Female 2004-12-30 0.00 ± 0.00 0.12 
MI00241 Adult Male 2004-08-24 0.00 ± 0.00 0.12 
MI00242 Adult Male 2004-08-24 0.13 ± 0.05 0.23 
MI00243 Adult Male 2004-08-26 0.00 ± 0.00 0.11 
MI00244 Adult Male 2004-09-04 0.00 ± 0.00 0.11 
MI00245 Adult Female 2004-09-07 0.00 ± 0.00 0.11 
MI00246 Adult Male 2004-09-07 0.00 ± 0.00 0.11 
MI00247 Teenager Male 2004-09-07 0.50 ± 0.07 0.31 
MI00248 Teenager Male 2004-09-07 0.00 ± 0.00 0.11 
MI00249 Pre-Teen Female 2004-09-08 0.00 ± 0.00 0.11 
MI00250 Child Female 2004-09-08 0.00 ± 0.00 0.11 
MI00251 Adult Male 2004-09-08 0.00 ± 0.00 0.11 
MI00252 Adult Female 2004-09-08 0.00 ± 0.00 0.11 
MI00253 Adult Male 2004-09-08 0.00 ± 0.00 0.12 
MI00254 Adult Male 2004-09-08 0.14 ± 0.05 0.22 
MI00255 Adult Male 2004-09-09 0.00 ± 0.00 0.11 
MI00256 Adult Male 2004-09-09 0.00 ± 0.00 0.11 
MI00257 Teenager Male 2004-09-09 0.00 ± 0.00 0.11 
MI00258 Adult Male 2004-09-09 0.00 ± 0.00 0.11 
MI00259 Adult Male 2004-09-09 0.00 ± 0.00 0.11 
MI00260 Adult Male 2004-09-13 0.43 ± 0.07 0.32 
MI00261 Adult Male 2004-09-13 0.13 ± 0.05 0.24 
MI00262 Adult Male 2004-09-14 0.00 ± 0.00 0.11 
MI00263 Adult Male 2004-09-15 0.00 ± 0.00 0.12 
MI00264 Teenager Male 2004-09-15 0.00 ± 0.00 0.11 
MI00265 Teenager Male 2004-09-15 0.00 ± 0.00 0.11 
MI00266 Teenager Male 2004-09-15 0.00 ± 0.00 0.11 
MI00267 Adult Female 2004-09-16 0.51 ± 0.08 0.34 
MI00268 Adult Male 2004-09-17 0.00 ± 0.00 0.11 
MI00269 Adult Male 2004-09-17 0.00 ± 0.00 0.12 
MI00270 Adult Female 2004-09-23 0.00 ± 0.00 0.11 
MI00271 Adult Female 2004-09-23 0.00 ± 0.00 0.11 
MI00272 Adult Male 2004-10-06 0.00 ± 0.00 0.11 
MI00273 Adult Male 2004-10-11 0.00 ± 0.00 0.11 
MI00274 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00275 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00276 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00277 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00278 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
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MI00279 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00280 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00281 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00282 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00283 Adult Female 2004-10-21 0.00 ± 0.00 0.11 
MI00284 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00285 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00286 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00287 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00288 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00289 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00290 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00291 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00292 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00293 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00294 Adult Male 2004-10-22 0.00 ± 0.00 0.11 
MI00295 Adult Female 2004-10-22 0.00 ± 0.00 0.11 
MI00296 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
MI00297 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
MI00298 Adult Female 2004-10-23 0.00 ± 0.00 0.11 
MI00299 Adult Female 2004-10-25 0.47 ± 0.07 0.33 
MI00300 Adult Female 2004-10-29 0.00 ± 0.00 0.11 
MI00301 Adult Female 2004-10-29 0.00 ± 0.00 0.11 
MI00302 Adult Female 2004-10-29 0.00 ± 0.00 0.11 
MI00303 Adult Female 2004-11-02 0.00 ± 0.00 0.11 
MI00304 Adult Male 2004-11-04 0.00 ± 0.00 0.11 
MI00305 Adult Male 2004-11-04 0.00 ± 0.00 0.11 
MI00306 Adult Male 2004-11-04 0.00 ± 0.00 0.11 
MI00307 Adult Male 2004-11-04 0.00 ± 0.00 0.11 
MI00308 Adult Male 2004-11-15 0.00 ± 0.00 0.11 
MI00309 Adult Female 2004-11-30 0.00 ± 0.00 0.12 
MI00310 Adult Female 2004-12-01 0.00 ± 0.00 0.12 
MI00311 Adult Male 2004-12-01 0.00 ± 0.00 0.11 
MI00312 Adult Male 2004-12-02 0.00 ± 0.00 0.11 
MI00313 Adult Female 2004-12-02 0.00 ± 0.00 0.11 
MI00314 Adult Female 2004-12-02 0.00 ± 0.00 0.11 
MI00315 Adult Male 2004-12-21 0.00 ± 0.00 0.11 
MI00316 Adult Male 2004-12-23 0.00 ± 0.00 0.11 
MI00317 Adult Female 2004-12-23 0.00 ± 0.00 0.11 
MI00318 Adult Female 2004-12-28 0.00 ± 0.00 0.11 
MI00319 Adult Male 2004-12-30 0.00 ± 0.00 0.12 
 
